We here report the retrospective analysis of 7 polymorphisms in 5 genes involved in the cellular response to cisplatin (DDP): ATM, ATR, Chk1, Chk2 and CDK12 in a cohort of 240 cancer patients with stage III/IV ovarian cancer underwent surgery and adjuvant chemotherapy. This evidence concerns the gene CHEK2 and ovarian carcinoma.